A reason of this good outcome could be searched probably in the tumor molecular characteristics, since it was the BRAF, KRAS, HRAS and TP53 wild type that could at least partially contribute to the good outcome, but codon 61 of the NRAS gene was mutated, possibly worsening the outcome. The gene discussed is KRAS; the disease is neoplasm.